Genetic Predictors of Benefit to Pembrolizumab (Q65393541)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Genetic Predictors of Benefit to Pembrolizumab |
clinical trial |
Statements
Identifying Genetic Predictors of Durable Clinical Benefit to Pembrolizumab in Advanced Non-small Cell Lung Cancer Alone and in Combination With Chemotherapy. (English)
0 references
31 May 2016
0 references
31 March 2019
0 references
90
0 references
18 year
0 references